Source,TTY

 1  HHC96DX|              Risk [C0150009] [A01.2]~Increased chance of an incapacity
 2  HHC96DX|              Risk [C0150012] [N33.1]~Increased chance of material into
 3  HHC96DX|              Risk [C0184549] [J24.2]~Increased chance of less than adequate
 4  HHC96DX|              Risk [C0150053] [J24.4]~Increased chance of more than adequate
 5  HHC96DX|              Risk [C0150032] [F15.2]~Increased chance of dehydration.~Fluid
 6  HHC96DX|              Risk [C0184536] [F15.4]~Increased chance of fluid retention,
 7  HHC96DX|              Risk [C0150047] [K25.5]~Increased change of contamination
 8  HHC96DX|         Injury Risk [C0150048] [N33]~Increased change of danger or loss.~
 9  HHC96DX|     Medication Risk [C0184544] [H21]~Increased chance of negative response
10  HHC96DX|              Risk [C0150078] [R46.3]~Increased chance of skin breakdown.~
11  HHC96DX|              of urine occurring with increased abdominal pressure.~Suffocation
12  HHC96DX|       Violence Risk [C0150090] [N34]~Increased change of harming self or
13  NAN94PT|            an individual experiences increased fluid retention and edema.~
14  NAN94PT|            than 50 ml occurring with increased abdominal pressure.~Incontinence,
15  NAN94PT|            which an individual is at increased risk for being invaded by
16  NIC96AC|             behaviors that are to be increased [C0508331] [U000241]~----~
17  NIC96AC|           Assist patient to tolerate increased levels of stress, as appropriate [
18  NIC96AC|        creating a timetable to guide increased responsibility in the future [
19  NIC96AC|             image has contributed to increased social isolation [C0510126] [
20  NIC96AC|          target behavior needs to be increased, decreased, or learned [
21  NIC96AC|          Discontinue stimulation, if increased pain or skin irritation
22  NIC96AC|              U002606]~----~Encourage increased calorie intake [C0510662] [
23  NIC96AC|              U002607]~----~Encourage increased fluid intake, unless contraindicated [
24  NIC96AC|              U002608]~----~Encourage increased intake of oral fluids, as
25  NIC96AC|              U002609]~----~Encourage increased intake of protein, iron,
26  NIC96AC|              U002610]~----~Encourage increased iron food intake, as appropriate [
27  NIC96AC|              U002611]~----~Encourage increased mobility and exercise, as
28  NIC96AC|              U002612]~----~Encourage increased oral intake of phosphate (
29  NIC96AC|              U002613]~----~Encourage increased responsibility for self,
30  NIC96AC|                 Encourage periods of increased activity, as appropriate [
31  NIC96AC|           any change in sensation or increased pain at the fracture site [
32  NIC96AC|              importance of reporting increased susceptibility to infection,
33  NIC96AC|      experiences overstimulation and increased disorientation from them [
34  NIC96AC|              U004711]~----~Lobby for increased drinking age [C0512740] [
35  NIC96AC|        adequate hydration to prevent increased blood viscosity [C0512772] [
36  NIC96AC|               Monitor ABG levels for increased pH level [C0512940] [U004920]~----~
37  NIC96AC|              physiological causes of increased confusion that may be acute
38  NIC96AC|              hypotonic solutions and increased water retention, secondary
39  NIC96AC|              14 mEq/L), signaling an increased production or decreased
40  NIC96AC|            Monitor for apprehension, increased anxiety, and changes in
41  NIC96AC|        pancreatic insufficiency, and increased dietary intake of calcium),
42  NIC96AC|             responses to fluid loss: increased heart rate, decreased BP,
43  NIC96AC|            U005268]~----~Monitor for increased actions of medications as
44  NIC96AC|            U005269]~----~Monitor for increased restlessness, anxiety, and
45  NIC96AC|               flaccid paralysis, and increased reflexes [C0513394] [U005389]~----~
46  NIC96AC|      motility, dizziness, confusion, increased sensitivity to digitalis,
47  NIC96AC|       impending renal failure (e.g., increased BUN and creatinine levels,
48  NIC96AC|            sponginess, receding, and increased bleeding [C0513460] [U005459]~----~
49  NIC96AC|                U005476]~----~Monitor increased filling of breasts in response
50  NIC96AC|          pain, relief of nausea, and increased peristalsis [C0513884] [
51  NIC96AC|              uterine contractions or increased uterine tone [C0514154] [
52  NIC96AC|           adventitious sounds and/or increased ventilatory pressures [C0514245] [
53  NIC96AC|            in whom disorientation is increased by overstimulation [C0514592] [
54  NIC96AC|        Provide adequate lighting for increased visibility [C0514628] [U006677]~----~
55  NIC96AC| understanding of transactions can be increased, as appropriate [C0515351] [
56  NIC96AC|             U007765]~----~Screen for increased intracranial pressure, capillary
57  NIC96AC|              reduced food intake and increased energy expenditure [C0515787] [
58  NIC96SA|           parents who demonstrate an increased need for parent education [
59  NOC97ID|              C0549461] [011510]~----~Increased muscle mass [C0543444] [
60  NOC97ID|              C0543444] [011508]~----~Increased muscle mass [C0700273] [
61  NOC97ID|                No urine leakage with increased abdominal pressure (e.g.,
62  NOC97ID|      C0517286] [130218]~----~Reports increased length of time between episodes [
63  NOC97ID|      C0516701] [140209]~----~Reports increased length of time between episodes [
64  NOC97IX|              C0549461] [NOCODE]~----~Increased muscle mass due to male
65  NOC97IX|              C0543444] [NOCODE]~----~Increased muscle mass due to female
66  OMS94SI|              C0042024] [P32S01]~----~increased muscle tone [C0549466] [
67  OMS94SI|              C0549466] [P27S05]~----~increased sensation [C0237295] [P27S07]~----~
68 PCDS97GO|             Patient will demonstrate increased orientation to current environment. [
69 PCDS97GO|             Patient will demonstrate increased impulse control. [C0548566] [
70 PCDS97GO|                    Patient will show increased tolerance for interaction
71 PCDS97GO|              nonverbally demonstrate increased comfort or tolerable level
72 PCDS97OR|       Monitor for edema secondary to increased cellular permeability. [